Copyright © 2025 Shenyang Dasan Pharmaceutical Technology Co., Ltd.
| Date | July 1, 1996 |
|---|---|
| CEO | YOO HYOUNG SUN |
| Capital | KRW 1.12 billion |
| Employees | 231 (as of Dec. 2024) |
| Business Scope | Pharmaceuticals, API manufacturing, wholesale & retail, export |
| Headquarters | (HQ) 13F, 70 Seonyu-ro, Yeongdeungpo-gu, Seoul (R&D Center) 3F, 304 Sinwon-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do |
| Factory | (Plant 1) 342 Deogam-ro, Dogoh-myeon, Asan-si, Chungcheongnam-do (Plant 2) 381 Deogam-ro, Dogoh-myeon, Asan-si, Chungcheongnam-do |
| Website | http://www.dspharm.com |
Current
Chairman, Korea Pharmaceutical Importers & Exporters Association
Chairman, Korea-Belgium Chamber of Commerce
Member, Korean Pharmaceutical Association
Former
Vice Chairman, Korea Pharmaceutical Importers & Exporters Association
Secretary General, Korea-Belgium Chamber of Commerce
Export Promotion Chair, Korea Pharmaceutical Importers & Exporters Association
Director, Korea Pharmaceutical Importers & Exporters Association
Public Relations Chair, Korea-Belgium Chamber of Commerce
Member, KISTI
Advisory Member, KOTRA
Member, SCH Bio-Med Center
Education
Advanced Course, Seoul National University College of Medicine
Doctoral Program, Sungkyunkwan University College of Pharmacy
Inspired by Dasan Jeong Yak-yong’s spirit of loving the people, Dashan Pharmaceutical is dedicated to developing and producing quality medicines for human health and happiness.
Address:70 Seonyu-ro, Yeongdeungpo-gu, Seoul
Area: 447.51㎡(13F)/133.58㎡(12F)
Business: Mgmt, Sales, Sourcing, BD
Address: 304 Sinwon-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do
Area: 899.34㎡
Facilities: Formulation equipment / R&D laboratory facilities
Business: Research and Development
Address: Room F9-310, No. 860-6, Shangshangou Village, Hunnan District, Shenyang City, Liaoning Province
Area: 899.34㎡
Facilities: Office facilities / R&D facilities
Business: R&D, Registration, Business Development in China
Address: 342 Asan-ro, Onyang-myeon, Asan-si, Chungcheongnam-do
Area: 3,166㎡
Business:Raw material & product manufacturing (international subsidiaries, domestic & Europe/America)
CAPA (Annual): 340 million tablets
Address: 381 Asan-ro, Onyang-myeon, Asan-si, Chungcheongnam-do
Area: 5,972㎡
Business: Manufacturing of oral solid dosage forms (tablets, capsules, packaging, etc.)
CAPA (Annual): 240 million tablets
Proprietary Finished Drugs
Building and manufacturing product portfolios focused on cardiovascular, respiratory, and urological systems.
Contract Manufacturing (CMO)
Contract manufacturing of Rx drugs via formulation & process optimization.
Pharmaceutical Key Intermediates & APIs
Development and patent acquisition of key pharmaceutical intermediates and APIs.
DMF registration management for newly synthesized and imported raw materials.
